Advertisement

Brain Imaging and Behavior

, Volume 12, Issue 1, pp 78–86 | Cite as

Self-reported confusion is related to global and regional β-amyloid: data from the Women’s healthy ageing project

  • Georgia E. McCluskey
  • Paul Yates
  • Victor L. Villemagne
  • Christopher Rowe
  • Cassandra E. I. Szoeke
Original Research

Abstract

Disease-modifying treatments for Alzheimer’s disease (AD) may require implementation during early stages of β-amyloid accumulation, well before patients have objective cognitive decline. In this study we aimed to assess the clinical value of subjective cognitive impairment (SCI) by examining the cross-sectional relationship between β-amyloid load and SCI. Cerebral β-amyloid and SCI was assessed in a cohort of 112 cognitively normal subjects. Subjective cognition was evaluated using specific questions on memory and cognition and the MAC-Q. Participants had cerebral β-amyloid load measured with 18F–Florbetaben Positron Emission Tomography (PET). No associations were found between measures of subjective memory impairment and cerebral β-amyloid. However, by self-reported confusion was predictive of a higher global β-amyloid burden (p = 0.002), after controlling for confounders. Regional analysis revealed significant associations of confusion with β-amyloid in the prefrontal region (p = 0.004), posterior cingulate and precuneus cortices (p = 0.004) and the lateral temporal lobes (p = 0.001) after controlling for confounders. An in vivo biomarker for AD pathology was associated with SCI by self-reported confusion on cross-sectional analysis. Whilst there has been a large body of research on SMC, our results indicate more research is needed to explore symptoms of confusion.

Keywords

Alzheimer’s disease Subjective cognitive impairment Subjective memory β-amyloid PET imaging Confusion 

Notes

Acknowledgements

We would like to acknowledge the contribution of participants, team members, partners and their supporters who have given their time and patience for over 20 years to the university. A full list of all researchers contributing to the WHAP and membership of our Scientific Advisory Board is available at www.whap.unimelb.edu.au. Funding for the WHAP has been provided by the Australian National Health and Medical Research Council (NHMRC 1062133, 547600, 1032350), Bayer Healthcare, the Ramaciotti Foundation, the Brain Foundation, the Alzheimer’s Association of Australia, the Australian Menopausal Society, the Shepherd Foundation, the Scobie and Claire Mackinnon Trust, the Collier Trust Fund, the J.O. & J.R. Wicking Trust, the Mason Foundation and the Alzheimer’s Association (NIA320312). Inaugural funding was provided by VicHealth and the NHMRC.

Compliance with ethical standards

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. Abdulrab, K., & Heun, R. (2008). Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. European Psychiatry, 23, 321–330.CrossRefPubMedGoogle Scholar
  2. Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., & Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 270–279.CrossRefGoogle Scholar
  3. Amariglio, R. E., Becker, J. A., Carmasin, J., Wadsworth, L. P., Lorius, N., & Sullivan, C. (2012). Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia, 50, 2880–2886.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Barnes, L. L., Wilson, R. S., Bienias, J. L., Schneider, J. A., Evans, D. A., & Bennett, D. A. (2005). Sex differences in the clinical manifestations of Alzheimer disease pathology. Archives of General Psychiatry, 62, 685–691.CrossRefPubMedGoogle Scholar
  5. Bayne, J. R. (1978). Management of confusion in elderly persons. Canadian Medical Association Journal, 118(2), 139–141.PubMedPubMedCentralGoogle Scholar
  6. Berry, B. (2014). Minimizing confusion and disorientation: cognitive support work in informal dementia caregiving. Journal of Aging Studies, 30, 121–130. doi: 10.1016/j.jaging.2014.05.001.CrossRefPubMedPubMedCentralGoogle Scholar
  7. Buckley, R., Saling, M. M., Ames, D., Rowe, C. C., Lautenschlager, N. T., Macaulay, S. L., & Ellis, K. A. (2013). Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. International Psychogeriatrics, 25, 1307–1315.CrossRefPubMedGoogle Scholar
  8. Cavagnoud, S., Losson, M., & Rossel, B. (2012). Acute confusion in the elderly. Assessment and preventive measures. Krankenpflege. Soins Infirmiers, 105(5), 52–55.PubMedGoogle Scholar
  9. Chetelat, G., Villemagne, V. L., Bourgeat, P., Pike, K. E., Jones, G., Ames, D., & Rowe, C. C. (2010). Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Annals of Neurology, 67, 317–324.PubMedGoogle Scholar
  10. Cole, M. G., & Primeau, F. J. (1993). Prognosis of delirium in elderly hospital patients. Canadian Medical Association Journal, 149(1), 41–46.PubMedPubMedCentralGoogle Scholar
  11. Cole, M., McCusker, J., Dendukuri, N., & Han, L. (2003). The prognostic significance of subsyndromal delirium in elderly medical inpatients. Journal of the American Geriatrics Society, 51, 754–760.CrossRefPubMedGoogle Scholar
  12. Comijs, H. C., Deeg, D. J., Dik, M. G., Twisk, J. W., & Jonker, C. (2002). Memory complaints; the association with psycho-affective and health problems and the role of personality characteristics. A 6-year follow-up study. Journal of Affective Disorders, 72, 157–165.CrossRefPubMedGoogle Scholar
  13. Crook, T. H., Feher, E. P., & Larrabee, G. J. (1992). Assessment of memory complaint in age-associated memory impairment: the MAC-Q. International Psychogeriatrics, 4, 165–176.CrossRefPubMedGoogle Scholar
  14. Darby, D. G., Brodtmann, A., Pietrzak, R. H., Fredickson, J., Woodward, M., Villemagne, V. L., & Rowe, C. (2011). Episodic memory decline predicts cortical amyloid status in community-dwelling older adults. Journal of Alzheimer's Disease, 27, 627–637.PubMedGoogle Scholar
  15. Dasgupta, M., & Brymer, C. (2014). Prognosis of delirium in hospitalized elderly: worse than we thought. International Journal of Geriatric Psychiatry, 29(5), 497–505. doi: 10.1002/gps.4032.CrossRefPubMedGoogle Scholar
  16. Davis, D. H., Muniz Terrera, G., Keage, H., Rahkonen, T., Oinas, M., Matthews, F. E., & Brayne, C. (2012). Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain, 135, 2809–2816.CrossRefPubMedPubMedCentralGoogle Scholar
  17. De Lange, E., Verhaak, P. F., & van der Meer, K. (2013). Prevalence, presentation and prognosis of delirium in older people in the population, at home and in long term care: a review. International Journal of Geriatric Psychiatry, 28, 127–134.CrossRefPubMedGoogle Scholar
  18. Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., & Pontecorvo, M. J. (2014). Florbetapir F18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. Molecular Psychiatry, 10, 1044–1051.CrossRefGoogle Scholar
  19. Downing, L. J., Caprio, T. V., & Lyness, J. M. (2013). Geriatric psychiatry review: differential diagnosis and treatment of the 3 D's - delirium, dementia, and depression. Current Psychiatry Reports, 15(6), 365. doi: 10.1007/s11920-013-0365-4.CrossRefPubMedGoogle Scholar
  20. Fong, T. G., Jones, R. N., Shi, P., Marcantonio, E. R., Yap, L., Rudolph, J. L., & Inouye, S. K. (2009). Delirium accelerates cognitive decline in Alzheimer disease. Neurology, 72(18), 1570–1575. doi: 10.1212/WNL.0b013e3181a4129a.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Francis, J., & Kapoor, W. N. (1992). Prognosis after hospital discharge of older medical patients with delirium. Journal of the American Geriatrics Society, 40(6), 601–606.CrossRefPubMedGoogle Scholar
  22. Gilewski, M. J., Zelinski, E. M., & Schaie, K. W. (1990). The memory functioning questionnaire for assessment of memory complaints in adulthood and old age. Psychology and Aging, 5, 482–490.CrossRefPubMedGoogle Scholar
  23. Han, J. H., Wilson, A., Vasilevskis, E. E., Shintani, A., Schnelle, J. F., Dittus, R. S., & Ely, E. W. (2013). Diagnosing delirium in older emergency department patients: validity and reliability of the delirium triage screen and the brief confusion assessment method. Annals of Emergency Medicine, 62(5), 457–465. doi: 10.1016/j.annemergmed.2013.05.003.CrossRefPubMedPubMedCentralGoogle Scholar
  24. Jack Jr., C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., & Aisen, P. S. (2013). Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurology, 12, 207–216.CrossRefPubMedPubMedCentralGoogle Scholar
  25. Jonker, C., Geerlings, M. I., & Schmand, B. (2000). Are memory complaints predictive for dementia? A review of clinical and population-based studies. International Journal of Geriatric Psychiatry, 15, 983–991.CrossRefPubMedGoogle Scholar
  26. Kammann, R., & Flett, R. (1983). Affectometer 2: a scale to measure current level of general happiness. Australian Journal of Psychology, 35, 259–265.CrossRefGoogle Scholar
  27. Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008). Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. Journal of Neuroinflammation, 5, 37. doi: 10.1186/1742-2094-5-37.CrossRefPubMedPubMedCentralGoogle Scholar
  28. Massoud, F., & Leger, G. C. (2011). Pharmacological treatment of Alzheimer disease. Canadian Journal of Psychiatry, 56, 579–588.CrossRefPubMedGoogle Scholar
  29. Merrill, D. A., Siddarth, P., Saito, N. Y., Ercoli, L. M., Burggren, A. C., Kepe, V., & Small, G. W. (2012). Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia. International Psychogeriatrics, 24, 1076–1084.CrossRefPubMedPubMedCentralGoogle Scholar
  30. Mintun, M. A., Larossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., & Morris, J. C. (2006). [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology, 67, 446–452.CrossRefPubMedGoogle Scholar
  31. Mori, T., Maeda, J., Shimada, H., Higuchi, M., Shinotoh, H., Ueno, S., & Suhara, T. (2012). Molecular imaging of dementia. Psychogeriatrics, 12, 106–114.CrossRefPubMedGoogle Scholar
  32. Nelson, J. E., Tandon, N., Mercado, A. F., Camhi, S. L., Ely, E. W., & Morrison, R. S. (2006). Brain dysfunction: another burden for the chronically critically ill. Archives of Internal Medicine, 166, 1993–1999.CrossRefPubMedGoogle Scholar
  33. Peres, K., Helmer, C., Amieva, H., Matharan, F., Carcaillon, L., Jacqmin-Gadda, H., & Dartigues, J. F. (2011). Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. A prospective population-based cohort. Journal of Alzheimer's Disease, 27, 39–47.PubMedGoogle Scholar
  34. Perrotin, A., Mormino, E. C., Madison, C. M., Hayenga, A. O., & Jagust, W. J. (2012). Subjective cognition and amyloid deposition imaging: a Pittsburgh compound B positron emission tomography study in normal elderly individuals. Archives of Neurology, 69, 223–229.CrossRefPubMedPubMedCentralGoogle Scholar
  35. Perry, V. H. (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain, Behavior, and Immunity, 18(5), 407–413. doi: 10.1016/j.bbi.2004.01.004.CrossRefPubMedGoogle Scholar
  36. Pietrzak, R. H., Scott, J. C., Neumeister, A., Lim, Y. Y., Ames, D., Ellis, K. A., & Maruff, P. (2014). Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study. British Journal of Psychiatry, 204, 400–401.CrossRefPubMedGoogle Scholar
  37. Pike, K. E., Ellis, K. A., Villemagne, V. L., Good, N., Chetelat, G., Ames, D., & Rowe, C. C. (2011). Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia, 49, 2384–2390.CrossRefPubMedGoogle Scholar
  38. Regazzoni, C. J., Aduriz, M., & Recondo, M. (2000). Acute confusion syndrome in the hospitalized elderly. Medicina, 60(3), 335–338.PubMedGoogle Scholar
  39. Resnick, S. M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D. P., & Wong, D. F. (2010). Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology, 74, 807–815.CrossRefPubMedPubMedCentralGoogle Scholar
  40. Riedel-Heller, S. G., Schork, A., Matschinger, H., & Angermeyer, M. C. (2000). Subjective memory loss--a sign of cognitive impairment in the elderly? An overview of the status of research. Zeitschrift für Gerontologie und Geriatrie, 33(1), 9–16.CrossRefPubMedGoogle Scholar
  41. Rockwood, K. (1989). Acute confusion in elderly medical patients. Journal of the American Geriatrics Society, 37(2), 150–154.CrossRefPubMedGoogle Scholar
  42. Rowe, C. C., Ackerman, U., Browne, W., Mulligan, R., Pike, K. L., O'Keefe, G., & Villemagne, V. L. (2008). Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurology, 7, 129–135.CrossRefPubMedGoogle Scholar
  43. Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., & Villemagne, V. L. (2010). Amyloid imaging results from the Australian imaging, biomarkers and lifestyle (AIBL) study of aging. Neurobiology of Aging, 31, 1275–1283.CrossRefPubMedGoogle Scholar
  44. Simpson, C. J. (1984). Doctors and nurses use of the word confusion. British Journal of Psychiatry, 145(4), 441–443. doi: 10.1192/bjp.145.4.441.CrossRefPubMedGoogle Scholar
  45. Szoeke, C. E., Robertson, J. S., Rowe, C. C., Yates, P., Campbell, K., Masters, C. L., & Desmond, P. (2013). The Women's healthy ageing project: fertile ground for investigation of healthy participants 'at risk' for dementia. International Review of nn, 25, 726–737.Google Scholar
  46. Thal, D. R., Rub, U., Orantes, M., & Braak, H. (2002). Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology, 58, 1791–1800.CrossRefPubMedGoogle Scholar
  47. Thurston, J. G. (1997). Management of acute confusion in the elderly. European Journal of Emergency Medicine, 4(2), 103–106.CrossRefPubMedGoogle Scholar
  48. Villemagne, V. L., Pike, K. E., Chetelat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., & Rowe, C. C. (2011). Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Annals of Neurology, 69, 181–192.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Georgia E. McCluskey
    • 1
    • 2
  • Paul Yates
    • 3
  • Victor L. Villemagne
    • 3
  • Christopher Rowe
    • 3
    • 4
  • Cassandra E. I. Szoeke
    • 1
    • 2
    • 5
  1. 1.Centre for Medical ResearchRoyal Melbourne HospitalParkvilleAustralia
  2. 2.Department of MedicineUniversity of MelbourneParkvilleAustralia
  3. 3.Department of Nuclear Medicine and Centre for PETAustin HealthHeidelbergAustralia
  4. 4.Florey Institute of Neuroscience and Mental HealthUniversity of MelbourneParkvilleAustralia
  5. 5.Institute for Health and AgeingMelbourneAustralia

Personalised recommendations